3. Umbruch 4.4..2005 - Online Pot

More documents

Recommendations

Info

VI Daniela Parolaro and Tiziana Rubino Cannabinoids and drugs of abuse . . . . . . . . . . . . . . . . . . . . . . . . . . . . 207 Francis Barth and Murielle Rinaldi-Carmona Cannabinoids in appetite and obesity . . . . . . . . . . . . . . . . . . . . . . . . . 219 Geoffrey W. Guy and Colin G. Stott The development of Sativex ® – a natural cannabis-based medicine . . 231 Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 265
Page 2: (( 3. Umbruch 4.4..2005 ))
Page 6: Cannabinoids as Therapeutics Edited
Page 10: Contents List of contributors . . .
Page 16: VIII List of contributors Piazza A.
Page 20: X Preface ing endocannabinoids with
Page 24: 2 E. Russo Good health in Ayurveda
Page 28: 4 E. Russo Table 1. Indian names fo
Page 32: 6 E. Russo The 18th century Persian
Page 36: 8 E. Russo fering from chronic rheu
Page 40: 10 E. Russo Similarly, by 1954, can
Page 44: 12 E. Russo (energy modality or pot
Page 48: 14 E. Russo Table 2. (Continued) Ca
Page 52: 16 E. Russo Hemorrhoids continue to
Page 56: 18 E. Russo 2 Merlin MD (2003) Arch
Page 60: 20 E. Russo 63 Karnick CR (1996) Ay
Page 64:
22 E. Russo medical use of cannabis
Page 68:
24 L.O. Hanusˇ and R. Mechoulam In
Page 72:
26 L.O. Hanusˇ and R. Mechoulam wh
Page 76:
28 L.O. Hanusˇ and R. Mechoulam we
Page 80:
30 L.O. Hanusˇ and R. Mechoulam St
Page 84:
32 L.O. Hanusˇ and R. Mechoulam (R
Page 88:
Page 92:
36 L.O. Hanusˇ and R. Mechoulam No
Page 96:
Page 100:
Page 104:
42 L.O. Hanusˇ and R. Mechoulam of
Page 108:
44 L.O. Hanusˇ and R. Mechoulam Ku
Page 112:
46 M. Maccarrone 117 Huffman JW, Ze
Page 116:
48 R.G. Pertwee ed that, in contras
Page 120:
50 R.G. Pertwee rats and mice at do
Page 124:
52 R.G. Pertwee prevent petit mal e
Page 128:
54 R.G. Pertwee Neurotoxicity As di
Page 132:
56 R.G. Pertwee Table 3. Anti-infla
Page 136:
58 R.G. Pertwee followed by sleep,
Page 140:
60 R.G. Pertwee or cancer against w
Page 144:
62 R.G. Pertwee cannabidiol with ph
Page 148:
64 R.G. Pertwee choactivity. In: DJ
Page 152:
Cannabinoids as Therapeutics Edited
Page 156:
Endocannabinoids and regulation of
Page 160:
Page 164:
Page 168:
Page 172:
Page 176:
Page 180:
Cannabinoids in neurodegeneration a
Page 184:
Page 188:
Page 192:
Page 196:
Page 200:
Page 204:
Page 208:
Page 212:
Page 216:
Page 220:
Page 224:
Page 228:
Page 232:
Page 236:
Page 240:
112 S.A. Varvel and A.H. Lichtman a
Page 244:
114 S.A. Varvel and A.H. Lichtman T
Page 248:
116 S.A. Varvel and A.H. Lichtman c
Page 252:
118 S.A. Varvel and A.H. Lichtman A
Page 256:
120 S.A. Varvel and A.H. Lichtman T
Page 260:
122 S.A. Varvel and A.H. Lichtman p
Page 264:
124 S.A. Varvel and A.H. Lichtman n
Page 268:
126 S.A. Varvel and A.H. Lichtman e
Page 272:
128 S.A. Varvel and A.H. Lichtman m
Page 276:
130 S.A. Varvel and A.H. Lichtman b
Page 280:
132 S.A. Varvel and A.H. Lichtman C
Page 284:
134 S.A. Varvel and A.H. Lichtman a
Page 288:
136 S.A. Varvel and A.H. Lichtman 8
Page 292:
138 S.A. Varvel and A.H. Lichtman u
Page 296:
140 S.A. Varvel and A.H. Lichtman d
Page 300:
142 R.E. Musty Since the discovery
Page 304:
144 R.E. Musty effects. Low doses s
Page 308:
146 R.E. Musty Discussion The data
Page 312:
Page 316:
Cannabinoid targets for pain therap
Page 320:
Page 324:
Page 328:
Page 332:
Page 336:
Page 340:
Page 344:
Page 348:
Potential use of cannabimimetics in
Page 352:
Page 356:
Page 360:
Page 364:
Page 368:
Page 372:
Page 376:
Page 380:
184 L.A. Parker et al. 5-HT 3 antag
Page 384:
186 L.A. Parker et al. ing nausea,
Page 388:
188 L.A. Parker et al. Cats and dog
Page 392:
190 L.A. Parker et al. [27] indicat
Page 396:
192 L.A. Parker et al. Anecdotal ev
Page 400:
194 L.A. Parker et al. specific to
Page 404:
196 L.A. Parker et al. References 1
Page 408:
198 L.A. Parker et al. 45 Mechoulam
Page 412:
200 L.A. Parker et al. norvegicus d
Page 416:
202 I.A. Bab signaling [20, 21] as
Page 420:
204 I.A. Bab cular and cellular bio
Page 424:
206 I.A. Bab 39 Iuliano-Burns S, Mi
Page 428:
208 D. Parolaro and T. Rubino (Amer
Page 432:
210 D. Parolaro and T. Rubino addic
Page 436:
212 D. Parolaro and T. Rubino Condi
Page 440:
214 D. Parolaro and T. Rubino plete
Page 444:
216 D. Parolaro and T. Rubino prote
Page 448:
218 D. Parolaro and T. Rubino Exp T
Page 452:
220 F. Barth and M. Rinaldi-Carmona
Page 456:
Page 460:
Page 464:
Page 468:
Page 472:
Page 476:
232 G.W. Guy and C.G. Stott However
Page 480:
234 G.W. Guy and C.G. Stott In the
Page 484:
236 G.W. Guy and C.G. Stott ∆ 9 -
Page 488:
238 G.W. Guy and C.G. Stott Figure
Page 492:
240 G.W. Guy and C.G. Stott For the
Page 496:
Page 500:
244 G.W. Guy and C.G. Stott oxide,
Page 504:
246 G.W. Guy and C.G. Stott Ireland
Page 508:
Page 512:
Page 516:
252 G.W. Guy and C.G. Stott Table 2
Page 520:
254 G.W. Guy and C.G. Stott of the
Page 524:
256 G.W. Guy and C.G. Stott reactio
Page 528:
Page 532:
260 G.W. Guy and C.G. Stott easily
Page 536:
262 G.W. Guy and C.G. Stott 40 Walt
Page 540:
Index AA-5-HT 156 absent-mindedness
Page 544:
Index 267 cannabinoid agonist 190,
Page 548:
Index 269 HU-210 93, 95, 142, 153,
Page 552:
Index 271 oxidative cell death 84 o
show all

3. Umbruch 4.4..2005 - Online Pot

Create successful ePaper yourself

Delete template?

Save as template?